EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluative Methodology for HRD Testing: Development of Standard Tools for Consistency Assessment

Zheng Jia iD, Yaqing Liu iD, Shoufang Qu iD, Wenbin Li iD, Lin Gao iD, Lin Dong iD, Yun Xing iD, Yadi Cheng iD, Huan Fang iD, Yuting Yi iD, Yuxing Chu iD, Chao Zhang iD und 17 weitere

Genomics, Proteomics & Bioinformatics · 10.05.2025 · 23 (1)

DOI: 10.1093/gpbjnl/qzaf017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genomics, Proteomics & Bioinformatics, online erschienen am 27.02.2025. Verfasst von Zheng Jia und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of In Vitro Diagnostic Reagent, National Institutes for Food and Drug Control (NIFDC), Beijing 100050, China. Hauptthemen laut MEDLINE: Genomic Instability, Homologous Recombination. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Homologous recombination deficiency (HRD) has emerged as a critical prognostic and predictive biomarker in oncology. However, current testing methods, especially those reliant on targeted panels, are plagued by inconsistent results from the same samples. This highlights the urgent need for standardized benchmarks to evaluate HRD assay performance. In phases IIa and IIb of the Chinese HRD Harmonization Project, we developed ten pairs of well-characterized DNA reference materials derived from lung, breast, and melanoma cancer cell lines and their matched normal cell lines, keeping each paired with seven cancer-to-normal mass ratios. Reference datasets for allele-specific copy number variations (ASCNVs) and HRD scores were established and validated using three sequencing methods and nine analytical pipelines. The genomic instability scores (GISs) of the reference materials ranged from 11 to 96, enabling validation across various thresholds. The ASCNV reference datasets covered a genomic span of 2340 to 2749 Mb, equivalent to 81.2% to 95.4% of the autosomes in the 37d5 reference genome. These benchmarks were subsequently utilized to assess the accuracy and reproducibility of four HRD panel assays, revealing significant variability in both ASCNV detection and HRD scores. The concordance between panel-detected GISs and reference GISs ranged from 0.81 to 0.94, with only two assays exhibiting high overall agreement with Myriad MyChoice CDx for HRD classification. This study also identified specific challenges in ASCNV detection in HRD-related regions and the profound impact of high ploidy on consistency. The established HRD reference materials and datasets provide a robust toolkit for objective evaluation of HRD testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genomic InstabilityHomologous RecombinationHumansCell Line, TumorDNA Copy Number VariationsReproducibility of Results

Stichwörter der Autor:innen

Homologous recombination deficiencyPerformance evaluationPrecision medicineReference datasetReference material

Autor:innen und Institutionen

  • Department of In Vitro Diagnostic Reagent, National Institutes for Food and Drug Control (NIFDC), Beijing 100050, China.
  • State Key Laboratory of Genetic Engineering, School of Life Sciences, Human Phenome Institute, and Shanghai Cancer Center, Fudan University, Shanghai 200438, China.
  • Department of Pathology, State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Coll…
  • GenePlus-Shenzhen Institute, Shenzhen 518000, China.
  • GenePlus-Beijing Institute, Beijing 102200, China.
  • Technology Development Center-Bioinformatics Group, BGI Genomics, Shenzhen 518081, China.

ORCID-Profile: Zheng Jia, Yaqing Liu, Shoufang Qu, Wenbin Li, Lin Gao, Lin Dong, Yun Xing, Yadi Cheng, Huan Fang, Yuting Yi, Yuxing Chu, Chao Zhang, Yanming Xie, Chunli Wang, Zhe Li, Zhihong Zhang, Zhipeng Xu, Yang Wang, Wenxin Zhang, Xiaoping Gu, Shuang Yang, Jinghua Li, Liangshen Wei, Yuanting Zheng, Guohui Ding, Leming Shi, Xin Yi, Jianming Ying, Jie Huang

Zitieren

APA

Jia, Z., Liu, Y., Qu, S., Li, W., Gao, L., Dong, L., Xing, Y., Cheng, Y., Fang, H., Yi, Y., Chu, Y., Zhang, C., Xie, Y., Wang, C., Li, Z., Zhang, Z., Xu, Z., Wang, Y., Zhang, W., …, & Huang, J. (2025). Evaluative Methodology for HRD Testing: Development of Standard Tools for Consistency Assessment. Genomics, Proteomics & Bioinformatics, 23(1). https://doi.org/10.1093/gpbjnl/qzaf017

Vancouver

Jia Z, Liu Y, Qu S, Li W, Gao L, Dong L, et al. Evaluative Methodology for HRD Testing: Development of Standard Tools for Consistency Assessment. Genomics, Proteomics & Bioinformatics. 2025;23(1). doi:10.1093/gpbjnl/qzaf017

BibTeX
@article{Jia2025,
  author = {Jia, Zheng and Liu, Yaqing and Qu, Shoufang and Li, Wenbin and Gao, Lin and Dong, Lin and Xing, Yun and Cheng, Yadi and Fang, Huan and Yi, Yuting and Chu, Yuxing and Zhang, Chao and Xie, Yanming and Wang, Chunli and Li, Zhe and Zhang, Zhihong and Xu, Zhipeng and Wang, Yang and Zhang, Wenxin and Gu, Xiaoping and Yang, Shuang and Li, Jinghua and Wei, Liangshen and Zheng, Yuanting and Ding, Guohui and Shi, Leming and Yi, Xin and Ying, Jianming and Huang, Jie},
  title = {Evaluative Methodology for HRD Testing: Development of Standard Tools for Consistency Assessment},
  journal = {Genomics, Proteomics & Bioinformatics},
  year = {2025},
  volume = {23},
  number = {1},
  doi = {10.1093/gpbjnl/qzaf017}
}
Kostenlos starten →